Stocks and Investing Stocks and Investing
Tue, October 30, 2012
[ 06:00 AM ] - United States, Market Wire
Business Growth-Grant of Options

NBIX, AXS, CRUS, FLML, DRE, INTT Expected To Be Down After Next Earnings Releases


Published on 2012-10-30 03:22:16 - WOPRAI
  Print publication without navigation


October 30, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Wednesday, October 31st 2012 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and December earnings reports. Neurocrine Biosciences Inc (NASDAQ:NBIX), Axis Capital Holdings Ltd (NYSE:AXS), CIRRUS LOGIC INC (NASDAQ:CRUS), Flamel Technologies SA (NASDAQ:FLML), Duke Realty Corp (NYSE:DRE), inTest Corp (NASDAQ:INTT) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Wednesday:

  Symbol  Company                          # of Reports         Quarter  Release Time
  NBIX    Neurocrine Biosciences Inc       12 Quarter           Q3       After
  AXS     Axis Capital Holdings Ltd        6 Quarter            Q3       After
  CRUS    CIRRUS LOGIC INC                 October Earnings     Q2       After
  FLML    Flamel Technologies SA           6 Quarter            Q3       After
  DRE     Duke Realty Corp                 6 Quarter            Q3       After
  INTT    inTest Corp                      12 Quarter           Q3       After
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Neurocrine Biosciences Inc (NASDAQ:NBIX) - Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. It develops drugs for endometriosis, anxiety, depression, pain, diabetes, irritable bowel syndrome, insomnia, and other neurological and endocrine-related diseases and disorders. Its products in clinical development include Elagolix, a phase II product for endometriosis; CRF1 Antagonist, a phase II product for mood disorders; CRF2 Peptide Agonist, a phase II drug for cardiovascular diseases; CRF1 Antagonist, a phase I product for treating mood disorders and irritable bowel syndrome; Vesicular Monoamine Transporter 2 Inhibitor, a phase I product for movement disorders and schizophrenia; and Elagolix, a phase I product for uterine fibroids, and mens and womens health. The companys research programs comprise Glucose Dependent Insulin Secretagogues for type II diabetes; Antiepileptic Drugs for epilepsy and bipolar disorder; and GnRH Antagonists for hormone dependent diseases and oncology. Its product pipeline also includes Indiplon 5mg and 10mg capsules, the FDA deemed approvable products, for the treatment of insomnia. The company has collaborations with GlaxoSmithKline to develop and commercialize CRF antagonists for psychiatric, neurological, and gastrointestinal diseases; Dainippon Sumitomo Pharma Co. Ltd. to develop and commercialize Indiplon in Japan; Abbott Laboratories to develop and commercialize elagolix for the treatment of endometriosis-related pain; and Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. Neurocrine Biosciences, Inc. was founded in 1992 and is headquartered in San Diego, California..

Axis Capital Holdings Ltd (NYSE:AXS) - AXIS Capital Holdings Limited, through its subsidiaries, provides various insurance and reinsurance products to insureds and reinsureds worldwide. It operates in two segments, Insurance and Reinsurance. The Insurance segment provides specialty insurance products, including property, marine, terrorism, aviation, credit and political risk, professional lines, liability, and employee medical coverage for self-insured, and small and medium sized employers. This segment offers its products through wholesale and retail brokers, managing general agents, and underwriters. The Reinsurance segment provides non-life reinsurance to insurance companies. Its product lines include catastrophe, which protects catastrophic losses; property that covers underlying personal lines and commercial property exposures; professional liability covering directors and officers liability, employment practices liability, medical malpractice, lawyers and accountants liability, environmental liability, and miscellaneous errors and omissions insurance risks; credit and bond, which include reinsurance of trade credit insurance products; motor coverage to insurers for motor liability losses; liability coverage, such as auto liability, general liability, and workers compensation; engineering coverage for various construction risks and risks associated with erection, testing, and commissioning of machinery and plants during the construction stage; and other products, including aviation, marine, personal accident, and crop reinsurance. In addition, AXIS Capital Holdings provides accident and health line products covering corporate personal accident and business travel accident products, association/affinity programs, and student accident and catastrophic health products. The company was founded in 2001 and is headquartered in Pembroke, Bermuda..

CIRRUS LOGIC INC (NASDAQ:CRUS) - Cirrus Logic, Inc. develops high-precision analog and mixed-signal integrated circuits (ICs). The company offers analog and mixed-signal audio converter and audio digital signal processor (DSP) products, which include analog-to-digital converters (ADCs); digital-to-analog converters (DACs); chips for integrating ADCs and DACs into an IC; digital interface ICs; volume controls; and digital amplifiers, as well as audio DSPs for consumer electronics applications, such as A/V receivers, digital TVs, and CobraNet ICs and modules for networked audio applications. Its audio products are used in various consumer applications, including audio/video receivers, DVD players and recorders, home theater systems, set-top boxes, MP3 players, gaming devices, sound cards, and digital televisions; professional applications comprising digital mixing consoles, multitrack digital recorders, and effects processors; automotive applications, which include amplifiers, satellite radio systems, telematics, and multi-speaker car-audio systems; and networked digital audio applications. The company also provides high-precision analog and mixed-signal ICs for energy control, energy measurement, and energy exploration applications; ICs, board-level modules, and hybrids for high-power PWM and power amplifier applications under the Apex Precision Power brand name; proprietary products, which include ADCs, DACs, linear amplifiers, PWM amplifiers, successive approximation register converters, and amplifier ICs; and system reference designs. It has operations in the United States, the Peoples Republic of China, the European Union, Hong Kong, Japan, South Korea, Taiwan, and the United Kingdom. The company sells its products through domestic sales force, external sales representatives, and distributors. Cirrus Logic, Inc. was founded in 1984 and is headquartered in Austin, Texas..

Flamel Technologies SA (NASDAQ:FLML) - Flamel Technologies S.A., a biopharmaceutical company, engages in the development of polymer-based drug delivery technologies for life science applications in France. The company develops products based on its nanoparticle Medusa technology, which provides controlled release following injection of therapeutic proteins, peptides, and other large and small molecules; multiparticle Micropump technology for oral administration of small molecule drugs with applications in controlled-release, taste-masking, and bioavailability enhancement; and Trigger-Lock technology to minimize the misuse and abuse of medications subject to abuse. Its products under development based upon Medusa technology include Interferon-alpha, a naturally occurring protein that the body uses for the treatment of Hepatitis C virus; and FT-105 long-acting basal insulin formulation to meet the basal insulin requirements of diabetic patients. The companys products based on its Micropump technology comprise Trigger Lock, an application that provides a technical solution for the societal problems of intentional and unintentional abuse and misuse of narcotics and other dangerous drugs; and Coreg CR, a formulation of carvedilol phosphate, which is used for the treatment of moderate to severe congestive heart failure, left ventricular dysfunction following myocardial infarction, and hypertension. Flamel Technologies has strategic alliance with Baxter International, Inc.; GlaxoSmithKline; Merck Serono; Pfizer; Corning S.A; and Corning Incorporated. The company was founded in 1990 and is headquartered in Venissieux, France..

Duke Realty Corp (NYSE:DRE) - Duke Realty Corporation operates as a real estate investment trust (REIT) in the United States. It offers leasing, property and asset management, development, construction, build-to-suit, and other tenant-related services. As of December 31, 2006, Duke Realty owned approximately 721 industrial, office, and retail properties comprising 113.8 million rentable square feet, as well as owned 6,400 acres of unencumbered land for development. The company has elected to be taxed as REIT under the Internal Revenue Code. As a REIT, it would not be subject to federal income tax purposes, provided that it distributes at least 90% of its REIT taxable income to its shareholders. The company was founded in 1972 and is headquartered in Indianapolis, Indiana with regional offices in Alexandria, Virginia; Atlanta, Georgia; Cincinnati, Columbus, and Cleveland, Ohio; Chicago, Illinois; Dallas and Houston, Texas; Minneapolis, Minnesota; Nashville, Tennessee; Orlando, Florida; Phoenix, Arizona; Raleigh, North Carolina; St. Louis, Missouri; and Tampa and Weston, Florida..

inTest Corp (NASDAQ:INTT) - inTEST Corporation, together with its subsidiaries, engages in the design, manufacture, and marketing of mechanical, thermal, and electrical products. Its products are used by semiconductor manufacturers in conjunction with automatic test equipment in the testing of integrated circuit (ICs) or semiconductors, including microprocessors, digital signal processing chips, mixed signal devices, micro-electro-mechanical systems, application specific ICs, and specialized memory ICs, which are used primarily in the automotive, aerospace, computer, consumer products, and telecommunications industries. The company operates in three segments: Mechanical Products, Thermal Products, and Electrical Products. The Mechanical Products segment provides the in2, M Series, Aero Series, and Cobal Series that hold various test heads and enable an operator to reposition a test head for alternate use with any one of several probers or handlers on a test floor. It also offers docking hardware products, which protect the delicate interface contacts and ensure repeatable alignment between the test head's interface board and the prober's probing assembly test socket. The Thermal Products segment offers ThermoChuck precision vacuum platform, ThermoStream temperature management systems, and MobileTemp Series to offer thermal test systems, as well as provides Thermal and Humidity Chambers, and Thermal Platforms. The Electrical Products segment offers various tester interfaces that provide the electrical connections between the tester and the wafer prober or IC handler to carry the electrical signals between the tester and the probe card on the prober or the test socket on the handler. inTEST sells its products directly, as well as through independent and commissioned sales representatives, and distributors to semiconductor manufacturers and semiconductor test subcontractors worldwide. The company was founded in 1981 and is headquartered in Cherry Hill, New Jersey..

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641


Contributing Sources